Videos Library

Event Videos

MedAffairs Leaders Forum USA

Boston - August 13-15, 2019

Leveraging online discussion platforms for optimal insight generation & stakeholder engagement

Related topics: Pharmaceutical/Biotech, Medical Affairs & Stakeholder Engagement, Global (non-specific)
Availability: FREE
  • Identify the logistical and resource barriers to domestic and global stakeholder engagement & insight retention
  • Learn about innovative communication solutions that leading organizations utilize to overcome these challenges and drive value-added insight development.
  • Discuss how to use these solutions to deliver improved engagement outcomes while maintaining regulatory compliance

Amy Pinelli
Regional Vice President, Business Partnerships



Strategic stakeholder and account planning in the era of precision medicine

Related topics: Pharmaceutical/Biotech, Medical Affairs & Stakeholder Engagement, Global (non-specific)
Availability: FREE

As the life sciences industry shifts its understanding of customers to help meet organizational goals, account management can help power strategic partnerships in an increasingly complex healthcare landscape. The session audience will learn: 

  • Key developmental stages of a multi-dimensional account management model, the specific value drivers in each stage, and how to effectively leverage current and emerging data
  • How to build a strategic key account management (KAM) program that enables effective planning, visualization, and execution across accounts and teams
  • How to leverage data to drive collaboration among stakeholders. 

Robert Groebel
Vice President - Global Medical/KAM Strategy
Veeva Systems


R[W]EVOLUTION: Accelerating Development & Commercialization with RWE

Related topics: Pharmaceutical/Biotech, Medical Affairs & Stakeholder Engagement, Real-World Evidence & Late-Phase Research, Global (non-specific)
Availability: FREE
  • Historically, product development has largely been disengaged from commercialization
  • However, in the current environment, health system stakeholders demand both clinical and real-world evidence to inform decisions regarding product use and reimbursement
  • This presentation will describe and illustrate with a case study the benefits of a Biopharmaceutical Acceleration Model approach to product development and commercialization, involving comprehensive evidence development to meet clinical, regulatory, and commercial needs

David Thompson
Senior Vice President Real World and Late Phase
Syneos Health